Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1000019, "name": "Alkem Lab", "stock_name": "Alkem Lab", "full_name": "Alkem Laboratories Ltd", "name_url": "stocks-analysis/alkem-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "5,540.05", "chg": 134.85, "chgp": "2.49%", "dir": 1, "prev_price": "5,405.20", "mcapval": "64,984.00 Cr", "mcap": "Mid Cap", "scripcode": 539523, "symbol": "ALKEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE540L01014", "curr_date": "May 06", "curr_time": "", "bse_nse_vol": "1.33 lacs", "exc_status": "Active", "traded_date": "May 06, 2026", "traded_date_str": "2026 05 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Alkem Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Valuation and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-upgraded-to-hold-by-marketsmojo-on-improved-valuation-and-technicals-3975294", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_mojoScore_3975294.png", "date": "2026-05-05 08:51:49", "description": "Alkem Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting improvements in valuation metrics and technical indicators despite flat recent financial performance. The mid-cap pharmaceutical company’s revised Mojo Score of 50.0 and Hold grade mark a significant shift driven by a combination of factors including enhanced valuation attractiveness, evolving technical trends, stable financial fundamentals, and solid quality parameters." }, { "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-3974658", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_valuationdot_3974658.png", "date": "2026-05-05 08:01:18", "description": "Alkem Laboratories Ltd has witnessed a notable improvement in its valuation parameters, prompting a reclassification from a Sell to a Hold rating with an upgraded valuation grade from fair to attractive. This shift reflects a more compelling price-to-earnings (P/E) and price-to-book value (P/BV) ratio relative to its historical averages and peer group, signalling a potential inflection point for investors assessing the pharmaceutical sector’s mid-cap landscape." }, { "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3973770", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_technicaldot_3973770.png", "date": "2026-05-04 08:02:17", "description": "Alkem Laboratories Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend as of late April 2026. Despite a modest day gain of 1.14%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments and what they imply for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Alkem Laboratories Gains 3.35%: 5 Key Factors Driving the Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-gains-335-5-key-factors-driving-the-weeks-mixed-momentum-3971534", "imagepath": "", "date": "2026-05-02 13:03:23", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> Sharp open interest surge and 2.29% price gain</p>\n <p><strong>28 Apr:</strong> Formation of Death Cross and technical downgrade</p>\n <p><strong>29 Apr:</strong> Mojo Grade downgraded to Sell amid valuation concerns</p>\n <p><strong>30 Apr:</strong> Bearish momentum intensifies with 1.26% price decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,228.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.5,40..." }, { "title": "Alkem Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-faces-bearish-momentum-amid-technical-downgrade-3969494", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlkemLaboratori_technicaldot_3969494.png", "date": "2026-04-30 08:03:06", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish territory. This downgrade in technical outlook accompanies a 1.26% decline in the stock price, reflecting growing investor caution amid mixed signals from momentum oscillators and moving averages." }, { "title": "Alkem Laboratories Downgraded to Sell Amid Technical and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-technical-and-valuation-concerns-3967636", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlkemLaboratori_mojoScore_3967636.png", "date": "2026-04-29 08:16:14", "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 28 Apr 2026. This revision reflects a combination of deteriorating technical indicators, a shift in valuation metrics, and a subdued financial trend, despite the company’s strong long-term returns and solid management efficiency." }, { "title": "Alkem Laboratories Ltd Faces Mildly Bearish Momentum Amid Technical Shifts", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-faces-mildly-bearish-momentum-amid-technical-shifts-3967515", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlkemLaboratori_technicaldot_3967515.png", "date": "2026-04-29 08:03:22", "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Recent technical indicators including MACD, RSI, moving averages, and Bollinger Bands suggest a nuanced market sentiment, prompting a downgrade in its Mojo Grade from Hold to Sell as of 28 April 2026." }, { "title": "Alkem Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-3967095", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlkemLaboratori_dealthcross_3967095.png", "date": "2026-04-28 18:00:25", "description": "Alkem Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium-term momentum and raising concerns about long-term weakness in the Pharmaceuticals & Biotechnology sector." }, { "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicators-3965658", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlkemLaboratori_technicaldot_3965658.png", "date": "2026-04-28 08:05:17", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of market forces and technical indicators. Despite a 2.29% gain on the day, the stock’s mixed signals across key metrics such as MACD, RSI, and moving averages suggest cautious optimism among investors navigating the Pharmaceuticals & Biotechnology sector." } ], "total": 559, "sid": "1000019", "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019" }, "announcements": [ { "caption": "US FDA Inspection At CompanyS Manufacturing Facility Located At Amaliya Daman", "datetime": "02-May-2026", "details": "Please find attached herewith Intimation about US FDA Inspection at Company s manufacturing facility located at Amaliya Daman.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Cessation", "datetime": "24-Apr-2026", "details": "Please find attached herewith intimation for Change in Key Managerial Personnel - Resignation of Chief Executive Officer", "source": "BSE" }, { "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations)", "datetime": "24-Apr-2026", "details": "Please find attached herewith intimation in respect of an order passed by Statutory Authority under the Income Tax Act 1961", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26", "dt": "2026-02-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Apr: Sharp open interest surge and 2.29% price gain

28 Apr: Formation of Death Cross and technical downgrade

29 Apr: Mojo Grade downgraded to Sell amid valuation concerns

30 Apr: Bearish momentum intensifies with 1.26% price decline

Read full news article

Alkem Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-04-30 08:03:06

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish territory. This downgrade in technical outlook accompanies a 1.26% decline in the stock price, reflecting growing investor caution amid mixed signals from momentum oscillators and moving averages.

Read full news article

Alkem Laboratories Downgraded to Sell Amid Technical and Valuation Concerns

2026-04-29 08:16:14

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 28 Apr 2026. This revision reflects a combination of deteriorating technical indicators, a shift in valuation metrics, and a subdued financial trend, despite the company’s strong long-term returns and solid management efficiency.

Read full news article

Alkem Laboratories Ltd Faces Mildly Bearish Momentum Amid Technical Shifts

2026-04-29 08:03:22

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Recent technical indicators including MACD, RSI, moving averages, and Bollinger Bands suggest a nuanced market sentiment, prompting a downgrade in its Mojo Grade from Hold to Sell as of 28 April 2026.

Read full news article

Alkem Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-04-28 18:00:25

Alkem Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium-term momentum and raising concerns about long-term weakness in the Pharmaceuticals & Biotechnology sector.

Read full news article

Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-04-28 08:05:17

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of market forces and technical indicators. Despite a 2.29% gain on the day, the stock’s mixed signals across key metrics such as MACD, RSI, and moving averages suggest cautious optimism among investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article